Phylogenetic and nucleotide sequence analysis of influenza A (H1N1) HA and NA genes of strains isolated from Saudi Arabia

Abstract

Introduction: In early 2009, a novel influenza A (H1N1) virus appeared in Mexico and rapidly disseminated worldwide. Little is known about the phylogeny and evolutionary dynamics of the H1N1 strain found in Saudi Arabia. Methodology: Nucleotide sequencing and bioinformatics analyses were used to study molecular variation between the virus isolates. Results: In this report, 72 hemagglutinin (HA) and 45 neuraminidase (NA) H1N1 virus gene sequences, isolated in 2009 from various regions of Saudi Arabia, were analyzed. Genetic characterization indicated that viruses from two different clades, 6 and 7, were circulating in the region, with clade 7, the most widely circulating H1N1 clade globally in 2009, being predominant. Sequence analysis of the HA and NA genes revealed a high degree of sequence identity with the corresponding genes from viruses circulating in the South East Asia region and with the A/California/7/2009 strain. New mutations in the HA gene of pandemic H1N1 (pH1N1) viruses, that could alter viral fitness, were identified. Relaxed-clock and Bayesian Skyline Plot analyses, based on the isolates used in this study and closely related globally representative strains, indicated marginally higher substitution rates than the type strain (5.14×10 -3 and 4.18×10 -3 substitutions/nucleotide/year in the HA and NA genes, respectively). Conclusions: The Saudi isolates were antigenically homogeneous and closely related to the prototype vaccine strain A/California/7/2009. The antigenic site of the HA gene had acquired novel mutations in some isolates, making continued monitoring of these viruses vital for the identification of potentially highly virulent and drug resistant variants.

Establishment of BALB/C mouse models of influenza A H1N1 aerosol inhalation

“…To establish animal models of H1N1 aerosol inhalation by simulating the natural infection, we chose to expose BALB/C mice to influenza A/California/07/2009, which has caused global pandemic outbreaks since 2009 and is responsible for the increased H1N1‐associated morbidity and mortality in China to date. Influenza A/California/7/2009 is still the prototype H1N1 strain recommended by the WHO for the current seasonal vaccine, and recent studies have revealed that other clades of H1N1 viruses are antigenically similar to the A/California/7/2009 strain …”

Novel Piperine compound AB05 (N-5-(3,4-dimethoxyphenyl) -2E,4E pentadienylpiperidine) inhibits H1N1 influenza virus propagation in vitro

“…The influenza virus is known for high mutation rate and complementary matching of the circulating virus and vaccine strains must be the same for successful vaccination. Further the available antiviral agents for influenza are costly and many times not available in adequate quantity (Al-Qahtani et al, 2017). Since the vulnerable population are the pediatric age group (0-4 years) the toxicity of the antiviral drugs amounts to the morbidity and adds to the burden of disease management.…”